Making an impact - Cancer Research UK

Making 

an impact 

Annual Review 2009/10

Cancer patients and their families 

are at the heart of everything we do. 

We have saved millions of lives with 

our groundbreaking work preventing, 

diagnosing and treating cancer. 

Our research is vital if we are 

to save more lives in the future. 

Harpal S Kumar 

Chief Executive Officer, Cancer Research UK 

Contents 

01 Welcome to our review of the year 

02 About us 

Research 

Research is our primary focus. We work in partnership 

with others to achieve the greatest impact in the global 

fight against cancer. 

05 Making your support count – a year of progress 

07 Leading the way in radiotherapy 

08 Looking to tomorrow 

Information 

We provide life-changing information to anyone affected 

by cancer and run awareness-raising initiatives so that 

cancer can be detected as early as possible and to help 

people reduce their risk of the disease. 

10 Raising awareness and saving lives 

Influencing public policy 

Our campaigning and work to influence government 

policy keeps cancer at the top of the political agenda. 

13 Campaigning for change 

Bringing our work together to save lives 

14 Diagnosing cancer early 

16 Driving world-class cancer research 

18 Our people 

20 Raising money to support our work 

22 How your donation helps us beat cancer 

25 Meet our Executive Board 

27 Get involved and find out more 

28 Thank you 

29 More about Cancer Research UK 

For more information about us and our work visit 

aboutus.cancerresearchuk.org/what-we-do 

We would like to say thank you to all those who feature within 

this Annual Review. 

Cover: Anna Robinson, seven, was diagnosed with acute lymphoblastic 

leukaemia in January 2006 after her mum took her to the doctors 

suffering with pains in her legs, appetite loss, exhaustion and a high 

temperature. She was treated until 2008 at the Royal Victoria Infirmary 

in Newcastle and is now doing well. Anna officially started 

the Middlesbrough Race for Life events in 2007 and 2008.

Welcome to our review 

of the year 

Life-saving information 

Accurate and straightforward information about cancer helps 

people to recognise signs and symptoms, encourages them to 

visit their GP as soon as possible, and provides them with 

better understanding if they are going through a cancer journey. 

Last year, more than 37,000 people visited our Cancer 

Awareness Roadshow, which toured the UK offering 

information about cancer and how to prevent it. And our 

award-winning patient information website, CancerHelp UK, 

regularly received over one million visits per month. 

It has been another very successful year 

for Cancer Research UK, with a number of 

achievements and promising scientific progress. 

Thanks to advances in our understanding 

of cancer, more new treatments are being 

developed at a faster pace than ever before. 

We would like to thank everyone who has helped make this 

possible. Our work is funded entirely by the public. All of our 

progress depends on the generosity of our supporters, the 

efforts of our fundraisers and volunteers and the dedication 

of our partners. 

World-class research 

More people are surviving cancer than ever before. People 

diagnosed with cancer are now twice as likely to survive for at 

least ten years as those diagnosed in the early 1970s. Our work 

has been at the heart of this progress. 

In April we were delighted to report a major research 

breakthrough – a term we rarely use. A 16-year study that 

we helped fund showed that a one-off five-minute screening 

test could cut the risk of developing bowel cancer by a third. 

The study also found that the test could reduce the number 

of deaths by 43%. Bowel cancer is currently the UK’s second 

biggest cancer killer. 

Thousands of cancer deaths could be avoided each year if 

cancer was diagnosed earlier. This year, we launched the 

research arm of the National Awareness and Early Diagnosis 

Initiative (NAEDI), which will inform our early diagnosis work 

to ensure as many people as possible survive cancer. 

New laws to protect our health 

Thanks to our research and campaigning, tobacco displays in 

shops and cigarette vending machines will be removed from 

2011 onwards across the UK and it will be illegal for under-18s 

to use sunbeds in England and Wales. In 2010, we made sure 

cancer was high on the agenda at the General Election, 

and we are working with the new government to ensure 

that cancer remains a priority. 

Working towards our vision 

Our five-year strategy and ambitious goals continue to guide 

our work and aspirations for the future. We have made some 

real progress this year. More treatments now exist with fewer 

side effects, the number of smokers is down and more people 

are aware of the lifestyle factors that can cause cancer. For 

more information see our Annual Report and Accounts at 

aboutus.cancerresearchuk.org/our-annual-publications 

We continue to need your support 

Nine out of ten donations to Cancer Research UK are £10 or 

less. But big or small, we make sure they are used in the best 

possible way. 

We ensure that every penny possible is spent on research. 

Last year, for every pound that we received, excluding our retail 

chain, over 80 pence was available to spend on our work to 

beat cancer. Despite the difficult financial backdrop, we raised a 

record £446 million, thanks to our generous supporters. But we 

receive no government funding for our research and we have 

no endowment, meaning that we have a continual need to raise 

funds if we are to make further progress through our 

life-saving work. 

We are proud of our achievements and grateful to everyone 

who donated to our shops, took part in events or volunteered 

their time and skills to us. There continue to be huge challenges 

ahead but, with your help, together we will beat cancer. 

In 2009 a record number of patients took part in our clinical 

trials which help to develop new treatments and set new 

standards of clinical practice. 

We continued to recruit and retain the best scientists and the 

quality of our research remains world-class, as measured by 

another excellent year for honours with 50 of our scientists 

receiving 28 different awards. 

David Newbigging 

Chairman 

27 July 2010 

Harpal S Kumar 

Chief Executive Officer 

27 July 2010 

Annual Review / Welcome to our review of the year / 01

About us 

Every two minutes someone in the UK hears 

the words ‘it’s cancer’. This devastating disease 

affects millions of lives every year worldwide 

and we are here to make sure as many people 

as possible survive. 

Why are we here? 

We believe that research is the key to beating cancer. 

Our work is entirely funded by the public – thanks to their 

generosity and support, our researchers lead the world in 

discovering new ways to prevent, diagnose and treat cancer. 

The chances of surviving cancer have doubled in the last 

40 years. More people are enjoying things they thought they 

might not live to see, and we have been central to that 

progress. But for every person who survives cancer, another 

does not. 

We have made a huge number of important discoveries which 

have changed the way cancer is prevented, diagnosed and 

treated. Yet our work remains essential because more than 

one in three of us will get cancer at some point in our lives. 

What do we do? 

Our aim is simple: we want to save lives by reducing the 

number of people who get cancer and helping more to survive 

the disease. But because a breakthrough can take decades 

of research, it’s a complex challenge. 

There are over 200 types of cancer which all involve the 

uncontrolled, abnormal growth of some of the body’s cells. 

We work to understand how cancers develop and spread, and 

design strategies to combat this. We are the only UK charity 

dedicated to beating all types of cancer. 

We research ways of preventing cancer and detecting it early, 

when it can usually be treated more successfully. Our work 

has already underpinned national screening programmes for 

breast, bowel and cervical cancer which are saving thousands 

of lives every year. 

We also raise awareness about cancer, providing information 

about prevention, symptoms, treatment and coping with the 

disease. And we campaign for new policies to ensure diagnosis 

is swift and the best treatment and care are available for all 

cancer patients across the UK. 


The breadth of our research is unparalleled – we fund the 

work of over 4,000 scientists, doctors and nurses around the 

UK. We play a vital role in supporting around 200 clinical trials 

aimed at improving cancer treatment and testing exciting new 

radiotherapy techniques and drugs. 

By funding all types of research – based in labs and clinical 

departments in hospitals and universities around the UK 

– we build productive working relationships between scientists, 

cancer doctors and nurses. Our work and expertise ensure 

that discoveries made on the laboratory bench are 

transformed into pioneering, life-saving treatments. 

Thanks to our research, around eight new cancer drugs 

are tested in clinical trials every year for the first time. 

Information 

Every year we help millions of people find the information they 

need to prevent, understand and cope with cancer. 

We help people recognise cancer symptoms and encourage 

them to go to their GP promptly. We also offer information 

about the importance and benefits of screening. We provide 

websites and publications and run health awareness campaigns 

aimed at health professionals and the public which highlight the 

steps people can take to help reduce their risk of cancer. 


We work with politicians, civil servants, policy-makers and the 

media to ensure that cancer stays at the top of their agenda, 

influencing legislation on important issues relating to cancer. 

We petition for better information on screening and rapid 

access to the best surgery, treatment and medicines and we 

run targeted campaigns for higher risk groups, such as over 

75s and disadvantaged social groups. Our scientists and 

doctors advise the parliaments in Westminster, Scotland, 

Wales and Northern Ireland on health and scientific policy. 

Looking to the future 

For over 100 years we have worked to beat cancer. We have 

helped to transform the way cancer is prevented, diagnosed 

and treated and our work has helped to save millions of lives, 

but we have so much more to do to achieve our vision of 

beating cancer. 

When I was diagnosed with cancer I thought my life was 

finished – now I’m doing well. I’m happy to support Cancer 

Research UK because future generations will benefit from 

the work that they do. 

Jayshree Jhala 

Breast cancer survivor 

02 / Annual Review / About us

Maggie Harrison, 49 

Bowel cancer survivor 

Maggie was initially treated for irritable bowel syndrome 

before she was diagnosed with bowel cancer in 2006. 

She underwent surgery to have the cancer and part of her 

bowel removed, followed by six months of chemotherapy. 

Three years on, Maggie, from Barrow-in-Furness, is feeling 

fitter than ever and keen to spread the message about 

early detection. 

6.45am 

8.00am 

9.30am 

1.00pm 

7.30pm 

Get up with my husband John so we can have 

breakfast together. I then exercise for about 

an hour. I’m in the best shape of my adult life. 

Call my mum. She was amazingly supportive 

when I was ill – we speak every day. 

I volunteer at my local community centre three 

mornings a week. We paint, draw, sew and knit, 

all things I missed doing during chemotherapy. 

Four afternoons a week I work at my local 

hospital, inputting data. 

Amateur dramatics rehearsal. It gives me 

a great buzz. 

43% 

A 16-year study that we 

helped fund showed that a 

one-off five-minute 

screening test could cut the 

risk of developing bowel 

cancer by a third, and 

reduce deaths from the 

disease by 43%, saving 

thousands of lives. 

Annual Review / About us / 03

Tyler Strong, 7 

Little Star and leukaemia survivor 

Tyler was diagnosed with acute lymphoblastic leukaemia 

when he was 18 months old. Suffering from appetite loss, 

listlessness and infections, he was sent for a bone marrow 

test at Manchester Children’s Hospital. Once the diagnosis 

was confirmed, Tyler was given intense chemotherapy in 

two blocks eight weeks apart. He finished his treatment in 

March 2008, is now doing well and helped us launch our 

new night-time walking marathon, Shine, in Manchester. 

Tyler was also nominated for our Little Star Award, which 

celebrates the courage of children with cancer. 

7.45am 

9.00am 

5.00pm 

7.30pm 

8.30pm 

Breakfast. Then, after vetting his packed lunch 

(he’s quite fussy!), Tyler has a quick play. He likes 

Lego and drawing on his whiteboard. 

School. Because he spent so much time 

in hospital away from his friends, it took 

Tyler some time to build up confidence, 

but he’s come on loads. 

Take Tyler to Beavers, which he loves. 

Dad picks him up and he runs riot for half 

an hour before having a shower and putting 

his pyjamas on. 

Bedtime – an hour later than normal 

on Beavers day. 

£10.3m 

We are a major funder 

of research into children’s 

cancer in the UK, and we 

have supported many of the 

world’s most successful 

trials of treatments for this 

varied group of diseases, 

benefitting thousands 

of children like Tyler. 

04 / Annual Review / Research


Making your support count – a year of progress 

We are a world leader in cancer research. 

Our scientists make cutting-edge discoveries 

in the lab that help us understand more about 

cancer every day – such as how it grows and 

spreads, and how our genes and lifestyle 

choices can increase our risk of developing the 

disease. Each of these advances is another 

step towards beating cancer. 

We are constantly searching for more effective treatments that 

accurately target cancer and have fewer side effects for patients. 

Our scientists and doctors have contributed to most of the top 

drugs used to treat patients worldwide today. Thanks to our 

leading role in developing treatments, hundreds of thousands 

of people have beaten the disease. 

Our researchers share their knowledge with cancer experts 

across the world – they work together to fight cancer and save 

even more lives. Here are just a few highlights of our progress 

this year. 

Tackling pancreatic cancer 

We have come one step closer to tackling pancreatic cancer. 

Our researchers led an international team that discovered why 

some patients stop responding to a commonly-used drug called 

gemcitabine. They found that pancreatic tumour samples have 

poor networks of blood vessels, making it harder for the drug 

to reach the tumour and treat the cancer effectively. 

We’re extremely excited by these results, as they may help 

explain the disappointing response of many people with 

pancreatic cancer to chemotherapy. Our new method 

of delivering chemotherapy to pancreatic tumours should 

make treatment more effective in the future. 

Dr David Tuveson 

Cambridge Research Institute 

Targeted screening for prostate cancer 

Our scientists are at the forefront of efforts to identify the 

common variations in our genes that influence cancer risk. 

Among several important discoveries this year, researchers in 

London and Cambridge identified nine new genetic variations in 

the human genome that can increase a man’s risk of developing 

prostate cancer. We hope that this discovery will enable more 

targeted screening. 

Saving precious time in the fight against ovarian cancer 

Our research helps doctors choose the right drugs for individual 

patients, saving precious time and avoiding unnecessary side 

effects. Our scientists discovered a pattern of genetic defects in 

tumours that could predict whether ovarian cancer patients will 

respond to common chemotherapy drugs. 

Choosing the right drug for the right patient is crucial. 

We hope that a simple test based on our research may one 

day save patients from unnecessary treatments and side 

effects. This will allow us to target the most effective drugs 

to those people who will really benefit. 

Dr Charles Swanton 

London Research Institute 

New hope for acute lymphoblastic leukaemia 

Our scientists in Manchester have brought hope to the one in 

five children with acute lymphoblastic leukaemia (ALL) who 

don’t respond to current treatments. They pinpointed a 

possible reason why some children become resistant or allergic 

to asparaginase, a drug used to treat virtually every child with 

ALL in the UK. Although there’s still a lot to do, the new results 

could mean that even more children will be cured in the future. 

In the 1960s, only around a quarter of children with 

cancer survived. Today, three-quarters survive, and 

our work has been at the heart of this huge progress. 

Preventing bowel cancer 

Could we find new ways to prevent one of the most common 

cancers? Our research is bringing us nearer every day. Scientists 

in Dundee uncovered fascinating new insights into a gene called 

GSTP showing that it protects against bowel cancer. And they 

are already investigating how to control it, to help stop the 

disease developing in the future. 

Improving breast cancer survival 

Our scientists used cutting-edge filming techniques to unravel 

how single breast cancer cells leave a tumour and start to move 

and spread around the body – something that until now has not 

been fully understood. This research will help scientists find ways 

to stop breast cancer in its tracks and help more people survive. 

My breast cancer was caught early. I feel lucky because 

it can be more difficult to treat cancer once it has spread. 

I think it’s fantastic news that researchers have found out 

how breast cancer cells move around the body. 

Pamina Brassey 

West London 

Annual Review / Research / 05

120,000 

Around 120,000 cancer 

patients in the UK benefit 

from radiotherapy each 

year, which is why we are 

investing heavily in 

research into the most 

effective ways to deliver it. 

Claire Daniels, 24 

Hodgkin’s lymphoma survivor 

Claire was 19 when she was diagnosed with Hodgkin’s 

lymphoma. She was initially treated with chemotherapy at 

Manchester’s Christie Hospital. But the cancer returned and 

Claire had further intense chemotherapy, radiotherapy and 

a stem-cell transplant. In between treatments, Claire 

organised a student ball and realised she wanted to be an 

event planner. Now 24, she’s healthy and works as a Special 

Events Executive for us. 

6.00am 

8.45am 

2.00pm 

8.00pm 

My alarm goes off. Eventually I get up and leave 

for the train station in Cambridge at 7am. 

Get into work. I’m on the phone a lot, talking to 

different supporters and looking for ways to raise 

money at our events. 

Meeting about our Emeralds & Ivy Ball, which 

promotes early diagnosis and raises awareness. 

Walk home from the train station, my boyfriend 

Steve and I have dinner together and watch 

some TV. 

11.00pm Bed. I’m normally pretty tired. The commute 

isn’t ideal but I’m lucky I can give something back. 

606 / / Annual Review / Contents / Research


Leading the way in radiotherapy 

W. Gillies McKenna, Director of Gray Institute for Radiation Oncology & Biology 

You might be surprised to learn that 

radiotherapy, the longest established 

treatment for cancer other than surgery, 

still helps cure more people than cancer drugs. 

Today, radiotherapy is kinder to patients, and 

every year, millions of patients benefit from 

this cornerstone of cancer treatment. 

Cancer Research UK helped establish the first treatment 

centres across the country as early as the 1920s, when 

radiotherapy research first began to take shape. 

Thanks to the unwavering support of the public since those 

early days of research, we’ve continued to make excellent 

progress in radiotherapy. It is now used to treat many cancers 

including breast, lung, bowel, brain and prostate. And today, 

four in ten people who beat cancer had radiotherapy as part 

of their treatment. 

As part of our five-year strategy, we aim to make radiotherapy 

more effective, targeting tumours more precisely with fewer 

and less severe side effects for patients. 

I took part in the PARSPORT trial, funded by 

Cancer Research UK. The idea was to test a more precise 

radiotherapy technique for head and neck cancer. The results 

were fantastic. I had virtually no side effects – I could eat, 

drink and taste perfectly normally. Thanks to the trial, I now 

lead a completely normal life again. 

David Jenkins 

Throat cancer survivor 

London 

Making radiotherapy more effective 

In 2007 we launched the Cancer Research UK-MRC 

Gray Institute for Radiation Oncology & Biology in Oxford. 

Scientists there are making important advances in radiotherapy 

research. They discovered that certain drugs can be used to 

‘prepare’ tumours for radiotherapy by increasing their blood 

supply, which makes them more sensitive to treatment. 

In a different approach, another team discovered a gene 

that could be blocked to make radiotherapy more effective. 

Both of these results from laboratory studies are crucial steps 

towards making radiotherapy even more effective for patients. 

Reducing side effects 

Improving radiotherapy also involves making it more tolerable 

for cancer patients. We’re at the forefront of international 

efforts to develop a type of radiotherapy that can be tailored 

to the size and shape of a tumour. Called Intensity Modulated 

Radiotherapy (IMRT), this approach allows doctors to 

maximise the dose of radiation to the cancer, while limiting 

damage to surrounding healthy tissue. Less damage means 

fewer side effects. 

This year, a trial funded by us showed that people with head 

and neck cancer given IMRT were much less likely to suffer 

from a dry mouth. This is the main side effect of treatment 

and it often causes debilitating problems with speech and 

eating and also increases the chance of ulcers and infections. 

This work could soon lead to a change in how all head and 

neck cancer patients are treated in the UK. 

Doctors prescribe radiotherapy treatments in numbers 

of ‘Gray’ – the unit measuring how much radiation your 

body absorbs. This is named after Hal Gray, an early 

pioneer in radiotherapy, whose research we funded 

from the 1930s to the 1960s and after whom the 

Oxford Institute is named. 

Less time in hospital, more time at home 

We’re helping to fund a pivotal trial, which recently showed 

that fewer but higher doses of radiotherapy are just as effective 

as standard radiotherapy for women with breast cancer. 

That means fewer trips to hospital – and more time at home. 

Cutting-edge treatments 

Our scientists are also exploring ingenious ways to help patients 

benefit more from radiotherapy. In Manchester, researchers 

are using ‘smart’ drugs to transport radiotherapy directly 

to tumours. Early results in certain types of lymphoma are 

encouraging, and we hope this treatment will reach clinics soon. 

Radiotherapy for the future 

Over the years we’ve made great leaps in understanding cancer, 

and radiotherapy technology has accelerated at an astonishing 

pace. But new technologies, and better evidence of the way 

that radiotherapy and other treatments can be used together, 

are placing increased demands on services. We need more 

radiotherapy machines, and people to operate them, to reduce 

waiting times and allow better access to treatment. We know 

that new radiotherapy technologies aren’t being rolled out 

in the UK as fast as they are in the rest of Europe. 

Cancer Research UK is asking the government to take steps 

to tackle these issues and, with the help of our supporters, 

we’ll continue to work hard to ensure that advances in 

radiotherapy benefit patients and that the UK remains 

a world leader in this field. 

For more information about our work in this area, visit 

www.cancerhelp.org.uk/about-cancer/treatment/ 

radiotherapy 



Looking to tomorrow 

To achieve our vision of beating cancer, 

we cannot afford to stand still. Every day 

our scientists and doctors are studying all 

aspects of cancer, from understanding the 

fine details of cell biology to cancer risk 

factors in entire populations. 

Here are some of the projects we are currently funding, 

highlighting just a few of the many ways we are investing 

in the breakthroughs of tomorrow. 

New trial offers hope for children with cancer 

Although rare, neuroblastoma is the most common cancer in 

children under five besides cancers of the blood. Six in ten 

children with neuroblastoma are successfully treated, but 

certain forms of the disease still remain difficult to treat. 

This year we launched a new international trial for children 

with a particularly difficult form of neuroblastoma, so we 

can learn more about how to tackle the disease. 

Our doctors hope to save the lives of more children in the 

UK by using cutting-edge ‘immunotherapy’ – a treatment that 

boosts the immune system to help fight cancer. 

Developing innovative ways to see cancer inside the body 

Finding ways to see cancer inside the body is vital for detecting 

the disease early – and at a stage when treatment is more 

likely to be successful. Also, we need ways to rapidly monitor 

whether therapy is working, so we can ensure people are 

getting the right treatment. 

Our scientists are developing techniques to see if cancer 

treatments such as chemotherapy and radiotherapy are 

working by looking at substances found in and around 

tumours. Crucially, they hope to detect these substances 

known as ‘biomarkers’ at a very early stage. This will allow 

doctors to tell if a treatment is working without having 

to wait to see if a tumour shrinks. 

This work could ultimately mean more people with cancer 

live for longer, and with a better quality of life. 

We can make an enormous difference through research. 

There are new drugs coming through and we are seeing 

changes in treatment approaches so we can try to cure 

people without damaging other tissues. This is a really 

exciting time, and if we have more money for research 

we will get much better treatments. 

Penelope Brock 

Consultant in Paediatric Oncology, neuroblastoma 

Targeting leukaemia at the roots 

Of the millions of cells that make up a tumour, a rare kind 

– called cancer stem cells – can fuel cancer growth but are 

particularly hard to treat. They not only produce ‘normal’ 

cancer cells that go on to divide many times, forming the 

bulk of a tumour, but also make new cancer stem cells. 

Current chemotherapy and radiotherapy treatments don’t 

destroy cancer stem cells, which explains why some people’s 

cancer can come back over time. 

Our scientists are investigating cancer stem cells in a type 

of leukaemia called CML. They are using sophisticated lab 

experiments to find the genes and proteins that keep these 

stem cells alive. This is the first step towards developing new 

treatments that specifically target cancer stem cells without 

harming healthy cells. 

We hope to discover drugs in the future that will completely 

eradicate this type of leukaemia. 

Predicting our risk of getting cancer 

One of the biggest challenges we face is finding ways 

to predict each person’s individual risk of developing cancer. 

This is because our risk depends on so many different things, 

including our age, lifestyle and genes. If doctors can identify 

people who are at a high risk of cancer, they can offer them 

tailored screening, monitoring, treatment and lifestyle advice. 

Our researchers are developing computer programmes 

to help doctors assess a person’s risk of developing certain 

cancers. They use information such as people’s genetic 

make-up and family history to make predictions. 

One programme, called BOADICEA, is already being used in 

clinics to help identify women under 50 who are most at risk of 

breast cancer. Our scientists are now fine-tuning this programme 

to make it as accurate as possible. They are also refining their 

risk assessment programme for ovarian cancer, and plan to 

develop a brand new programme for prostate cancer. 

Some of our research objectives for 2010/11 

— Continue to fund the best research to deepen our 

understanding of cancer, including increasing our focus 

on unravelling how our genes, lifestyle and environment 

interact to cause cancer. 

— Promote and fund research on cancers that have the 

poorest survival rates – such as oesophageal, lung and 

pancreatic cancer. 

— Work on new research and initiatives in radiotherapy, 

surgery and in combining treatments to boost survival. 

For more detailed information on these objectives visit 


08 / Annual Review / Research

Dr Penelope Brock, 56 

Consultant in Paediatric Oncology, neuroblastoma 

Penelope works at Great Ormond Street Hospital in 

London. She is leading the UK part of an international clinical 

trial we are funding into a high-risk form of the childhood 

cancer called neuroblastoma. The trial is looking at using a 

new kind of treatment called immunotherapy, which aims 

to trigger the body’s immune system to help stop the cancer 

or prevent it from coming back. 

6.00am 

8.25am 

9.00am 

1.30pm 

3.00pm 

7.30pm 

My husband Paul wakes me with a cup of tea. 

Catch the train from Tonbridge to Waterloo 

East. Read the Metro and then edit a draft 

trial report. 

Pick up a cappuccino, check my emails 

– reply to European colleagues on the high-risk 

neuroblastoma trial. 

Start clinic. A busy day ahead – I have a 

telephone conference on a liver tumour trial 

and I supervise junior doctors. 

Take sandwich to ward round. 

See patients on the daycare ward. 

Eat supper and enjoy the evening with 

my children, Ben and Izzy. 

Over 4,000 

Thanks to our supporters, 

we fund the work of over 

4,000 researchers, nurses 

and doctors like Penelope 

in the UK. 


Information 

Raising awareness and saving lives 

We provide information on every aspect 

of cancer, from prevention and detection 

to treatment and care. 

Our award-winning website, CancerHelp UK, helps people 

with cancer understand their illness and make informed 

decisions, by providing comprehensive information about 

cancer and its treatment. 

Our team of cancer information nurses answer questions by 

phone and email and the Spot Cancer Early and Healthy Living 

sections of our website include information on how we can 

spot the signs and symptoms of cancer early and make lifestyle 

changes to reduce the risk of the disease. We also run 

awareness campaigns such as SunSmart, to prevent skin cancer. 

Our information for health professionals includes newsletters 

for GPs and practice nurses with information including risk 

factors, screening and early detection as well as a dedicated 

section of our website providing up-to-date statistics and key 

facts on cancer. And to help people understand more about 

cancer research and the latest advances, we also have an 

award-winning science blog. 

scienceblog.cancerresearchuk.org 

Raising awareness of signs and symptoms 

We know that thousands of cancer deaths could be avoided 

each year if people were diagnosed at an earlier stage. 

Together with the Department of Health and National Cancer 

Action Team (NCAT), we formed the National Awareness 

and Early Diagnosis Initiative (NAEDI). NAEDI’s work will help 

ensure doctors can diagnose cancer earlier, and encourage 

people with symptoms that could be cancer to seek advice 

quickly from a specialist. We targeted people at increased 

risk of certain cancers in a variety of ways, raising awareness 

of symptoms and encouraging them to visit the doctor. 

Our activities over the year included producing films that 

explained the symptoms of different cancers and running 

an online campaign to encourage over 50s – those most 

at risk – to view them, and talking to the Bangladeshi 

community in Tower Hamlets about oral cancer. 

Changes to public attitudes along with changes within the 

healthcare system will be fundamental to making a difference. 

Cancer is more likely to be treated successfully when it’s 

spotted early. 

Professor Jane Wardle 

Cancer Research UK’s Health Behaviour Research Centre, 

University College London 

Our patient information website, CancerHelp UK, 

is the most visited cancer site in the UK and regularly 

received over one million visits per month last year. 

Targeting lifestyle changes 

Up to half of all cancers could be prevented through lifestyle 

changes. For example, keeping a healthy body weight can greatly 

reduce the risk of cancer. Similarly, enjoying the sun safely and 

not using sunbeds actually reduces the risk of skin cancer. 

During the year we worked with the British Heart Foundation 

and Diabetes UK on the Active Fat campaign, which highlights 

how carrying excess weight around your middle can increase 

the risk of cancer, heart disease and Type 2 diabetes. We also 

supported the NHS, who produced TV adverts about the 

risks of drinking too much alcohol. 

Our award-winning skindividual campaign encourages young 

people to use social networking sites to spread sun protection 

messages. According to our research, in the last six years the 

number of people who seek out shade, cover up and avoid 

sunbeds, and who know the importance of checking their 

moles, has increased significantly. 

Our Cancer Awareness Roadshow toured the UK, giving 

information and support on cancer. More than 37,000 people 

visited in 2009, and over 8,500 had consultations with our 

nurses. Nine out of ten of those interviewed said they would 

change their behaviour as a result of their visit. 

Informing people about clinical trials and research 

Clinical trials are an essential part of our work to beat cancer. 

But it is hard for patients to find out about research into 

treatment for their cancer type. 

Our unique clinical trials database lists easy-to-read summaries 

of clinical trials, which patients can print and take to their own 

specialists. The revamped database is now easier to use than 

ever, listing around 350 open trials in the UK, as well as closed 

trials and trial results. 

www.cancerhelp.org.uk/trials 

Some of our information objectives for 2010/11 

— Drive progress on diagnosing cancer earlier, including 

finding out more about why people experience delays 

between seeing their GP and getting the hospital 

appointment they need. 

— Promote earlier diagnosis of breast, bowel and lung 

cancer in particular, and support the NHS to do the same. 

Find out how to reduce your risk of cancer at 

info.cancerresearchuk.org/healthyliving 

10 / Annual Review / Information

Jayshree Jhala, 73 

Early detection campaigner and breast cancer survivor 

Jayshree was diagnosed with breast cancer following a 

mammogram when she was 69. She chose to have a 

mastectomy and chemotherapy and is now on a five-year 

course of tamoxifen. Jayshree promotes cancer awareness 

in schools and community centres in Luton to her local 

Asian community. 

1,000 

Our specialist nurses 

respond to up to 1,000 

enquiries every month 

from people like Jayshree, 

affected by or concerned 

about cancer. Around one 

in five of these enquiries 

is about breast cancer. 

6.30am Wake up. I feed Simba, our Alsatian. He’s just 

over a year old and like a lion. 

7.30am Prepare breakfast for my grandchildren Arjun 

and Shiv – they’re the apples of my eye. 

10.00am Attend a cooking class, meeting, or do some 

paperwork. I work for Luton Primary Care Trust 

as a community food adviser. 

1.30pm Have my main meal with my husband, Govind. 

He has a cancerous tumour near his urethra. 

We encourage each other to be positive and 

get over our illnesses, so we can still enjoy our 

lives together. 

7.00pm Have a snack with Govind. I used to swim in the 

evenings and I’m building up the courage to go 

again after my mastectomy. 

8.00pm Watch TV, make a few phone calls and relax 

with my family and Simba before going to bed. 

Annual Review / Information / About us / 11

Justine Sheils, 39 

SunSmart campaigner and skin cancer survivor 

Sun-lover Justine regularly used tanning beds from the age 

of 15, and rarely applied sunscreen when on holiday. In 2004 

she noticed a mole on her chest but didn’t get it checked 

out for a further 18 months. When she did, a specialist 

diagnosed malignant melanoma. Liverpool-based Justine had 

the mole removed and is now back to full health. She is a 

passionate supporter of our SunSmart campaign. 

£13.3m 

We are the largest funder 

of skin cancer research in 

the UK. Our broad 

research programme 

ranges from uncovering the 

causes of the disease to 

developing new treatments 

for people like Justine. 

5.00am 

8.00am 

4.00pm 

6.00pm 

Get up and go for a 45-minute run – it helps get 

rid of all of my anxieties. When I was ill, 

my aim was to put my trainers back on. 

Start work at my local hospital where I’m an 

administrator. I have gone part-time because 

I’ve realised what’s important in life. 

Finish work and head home for some 

chill-out time. 

College. I’m training to be a sports therapist. 

I’ve realised that life’s too short to not follow 

your dreams. 

10.00pm Head to bed. I’m pretty exhausted 

on college nights. 

12 / Annual Review / Contents Influencing public policy


Campaigning for change 

We need to make sure cancer stays 

at the top of the national health agenda. 

Influencing politicians is a vital part of this. 

We work with decision-makers in Westminster, the Scottish 

Parliament, the Welsh Assembly, the Northern Ireland Assembly 

and the European Parliament. We make sure the views of 

patients, researchers, health professionals, volunteers and 

supporters are heard at all levels of government. 

The 2010 General Election 

We knew that cancer would be a big issue in the General 

Election. We wanted to make sure all parties were backing 

steps to prevent cancer and detect it earlier as well as making 

sure the UK has the funding and resources needed to carry out 

high quality research. We also wanted to see MPs commit to 

improving access to treatment and reducing inequalities between 

social groups, as we know that the risk of dying of cancer is far 

greater in less affluent communities. 

We published a new manifesto and a Guide to Campaigning 

about Cancer for prospective parliamentary candidates (PPCs). 

We met key ministers, policy advisers, MPs and PPCs, and asked 

our supporters to contact candidates in their constituency and 

urge them to ‘Commit to Beat Cancer’ if elected. 

Over 1,000 parliamentary candidates signed our pledge 

to help make the UK’s cancer outcomes among the best 

in Europe and more than 250 of those have gone on 

to become MPs. Find out more at 

www.cancercampaigns.org.uk/ourcampaigns/commit 

Planning for the future of cancer services 

National cancer plans are a vital way to make sure we have 

the best cancer services. They detail each government’s plans 

to invest in and reform cancer services, and provide direction 

for using resources effectively. We monitor how these plans 

are implemented from spending commitments to passing new 

legislation – to ensure promises are kept on key issues. 

We wrote an in-depth report on how the cancer plans 

in England, Scotland, Wales and Northern Ireland were 

implemented, and what progress they have made. 

Our research included interviews with scientists, clinicians 

and NHS professionals. We reviewed information available 

to people with cancer, to help us understand how people’s 

experiences have changed since the cancer plans have been 

in place. Results showed there has been progress in some 

areas. We will continue to push governments to ensure the 

best cancer services are available to patients throughout the UK. 

Protecting young people 

Smoking is the single biggest preventable cause of cancer in the 

world. A large number of studies have shown that quitting the 

habit can greatly reduce the risk of smoking-related cancers. 

The earlier you stop, the better. Reaching young people early 

so they don’t start smoking is an important part of our fight 

against cancer. 

Over 12,000 of our supporters wrote to MPs and MSPs backing 

our ‘Out of Sight, Out of Mind’ campaign, which called for a 

ban on tobacco marketing to young people. More than 50,000 

people signed our petition. Our supporters helped convince 

MPs and MSPs to vote to end the display of tobacco at the 

tills in shops and supermarkets across the UK and to stop 

cigarettes being sold in vending machines in England, Scotland, 

Wales and Northern Ireland. This will be phased in from 2011. 

Reducing the risk of skin cancer 

Malignant melanoma – the most serious type of skin cancer 

– is one of the most common cancers in the UK. Using a 

sunbed once a month or more can increase the risk of this 

type of cancer by more than half, and the number of people 

who develop it is increasing. 

We met politicians, civil servants and health campaigners to push 

for new laws to stop under-18s using sunbeds. We also wanted 

to make sure all salons are staffed and customers receive 

accurate health information. Thanks to thousands of emails 

from our supporters, MPs and Peers from all parties voted 

in favour of the Sunbeds Act, which will become law in 2011 

in England and Wales. 

Some of our influencing public policy objectives for 2010/11 

— Raise awareness of the importance of radiotherapy 

as a cancer treatment and the need for better services. 

— Keep cancer high on the agenda following the General 

Election and prepare for elections in the Scottish 

Parliament, Welsh Assembly and Northern 

Ireland Assembly. 

To read more about the issues and how you can 

call for change, visit 

www.cancerresearchuk.org/publicpolicy 

Annual Review / Influencing public policy / 13

Bringing our work together to save lives 

Diagnosing cancer early 

Sara Hiom, Director of Health Information, Cancer Research UK 

If only my cancer had been spotted earlier. 

We’re determined to make statements like this 

a thing of the past. Thousands of deaths could 

be avoided each year if cancer was diagnosed 

and subsequently treated at an earlier stage. 

This is probably the single biggest reason why 

cancer survival rates in the UK are lower than 

in many other countries in Europe. 

At the moment, just over half of all people with cancer are 

diagnosed at a stage when it can be successfully treated. 

Our goal is to see this rise to two-thirds by 2020 by tackling 

late diagnosis through our research, our information and 

influencing health policy. 

Our research underpins the national screening programmes 

for breast and cervical cancers. Both mean more women are 

diagnosed when treatment is likely to be successful. Since 

national breast screening began in 1988, around five million 

women in England have been screened and over 100,000 

cancers detected. And the cervical screening programme 

has prevented an epidemic of cervical cancer. Thanks to our 

supporters, we’re building on these successes. 

Our research 

In a major breakthrough this year, our scientists found that a 

one-off five minute screening test could prevent one-third of 

bowel cancers and reduce deaths by 43%. Bowel cancer is the 

second biggest cancer killer in the UK, and the third most 

common cancer. We’re now calling on UK governments to add 

the test to the national bowel cancer screening programme. 

This could save thousands of lives and spare families the anxiety 

and suffering associated with a cancer diagnosis. 

We’re also helping to fund a major trial to see whether a national 

screening programme for ovarian cancer should be introduced 

which could detect the disease early enough to save lives. 

And as part of a national prostate cancer trial, we’re supporting 

important research to help decide if the PSA blood test – which 

can help identify prostate cancer – could form the basis of a 

national screening programme. 

We’re leading the research arm of the National Awareness and 

Early Diagnosis Initiative (NAEDI), a new National Cancer 

Research Institute partnership, formed to fund high-quality 

research in areas likely to have the greatest impact on tackling 

late diagnosis. 

Our information 

Together with the Department of Health and the National 

Cancer Action Team, NAEDI coordinates activity to promote 

the earlier diagnosis of cancer. We’ve been raising awareness 

of the importance of detecting cancer at an early stage with 

the public and GPs, as well as trying to better identify who 

is most at risk. 

We supported NHS Derby City in campaigning to raise 

awareness of bowel cancer in communities with a greater than 

average risk of cancer and to encourage men over 50 to visit 

their GP if they notice anything unusual, and we worked with 

Merseyside and Cheshire Cancer Network to tell older men 

about symptoms of skin cancer. 

Early diagnosis is our next big challenge in cancer and 

will be crucial in bringing our survival rates up to the 

best in Europe. 

Professor Sir Mike Richards 

National Cancer Director 

Influencing health policy 

We want UK governments to make early diagnosis of cancer 

a priority. During the election campaign we promoted the 

importance of early diagnosis to thousands of parliamentary 

candidates. We called on politicians to adopt the new bowel 

screening test and we are urging them to increase the number 

of people invited for cancer screening. 

We held a discussion day for people with cancer and their 

families to help understand their experiences of being diagnosed 

and to inform our own work with policy-makers. 

The future 

We’re pushing for policies that encourage people to visit their 

GP with signs or symptoms of cancer, and for speedy referrals. 

We want policies that support GPs and help the public to 

understand as much as possible about the benefits of 

early diagnosis. 

By catching cancer earlier we can help ensure that the UK’s 

outcomes are among the best in Europe and globally 

– instead of being behind most Northern European countries. 

For information on detecting cancer early visit 

www.spotcancerearly.com 

With our partners we are investing up to £7.5 million over five 

years in such research. For more information see 

www.naedi.org.uk 

14 / Annual Review / Diagnosing cancer early

Calvin Wood, 68 

Prostate cancer survivor 

Calvin, a grandfather of four, was diagnosed with prostate 

cancer in 2001. He received hormone treatment – Casodex 

and Zoladex – and a six-week course of radiotherapy. 

Calvin now devotes much of his time to supporting other 

men with the disease. He set up a prostate cancer support 

group at the hospital, on the Wirral, where he was treated, 

which now has more than 180 members. 

8.00am 

Get up and have breakfast with my wife. 

The mornings are my ‘free time’ for doing 

any shopping or jobs around the house. 

10.00am Contact members of the prostate cancer 

support group. It’s wonderful to help others 

in the same boat, particularly those struggling 

to come to terms with a diagnosis. 

2.00pm 

7.00pm 

Meetings. I’m treasurer of the National 

Conference of Cancer Self-Help Groups and 

a trustee of the Clatterbridge Centre for 

Oncology. I feel I’m giving something back. 

Go for a meal with friends or catch up with 

family news. Having cancer helps you focus 

on what’s important, like friends and family. 

10.00pm Watch the news, then bed – 24 hours doesn’t 

seem long enough! 

Seven out 

of ten men 

now survive prostate 

cancer for at least ten 

years, compared with only 

two out of ten in the 1970s. 

We fund research at all 

levels, from uncovering 

the disease’s causes to 

developing new treatments. 

Annual Review Annual / Diagnosing Review cancer / About early us / 15

Driving world-class cancer research 

The breadth of our work is 

unparalleled. We are tackling 

cancer from all angles and 

support research in many 

different ways. 

To make sure advances in cancer 

research benefit as many people as 

quickly as possible, we fund scientists, 

doctors and nurses across the UK. 

We have five core research Institutes, 

each specialising in different areas 

of cancer. We also form lasting 

partnerships and networks – with the 

NHS, universities and other charities 

– both in the UK and internationally. 

Our Centres 

As well as undertaking world-class 

research, our growing UK-wide network 

of Centres helps train the clinical and 

scientific research workforce of the 

future. Each Centre is a ‘virtual hub’ 

that unites researchers, patients and 

fundraisers, giving them the opportunity 

to work together to raise awareness of 

cancer research and host events in the 

local community. 

We launched seven more Centres 

in 2009/10, bringing our total launched 

to ten, and we plan to have between 

15 and 20 by the end of 2011. In this 

Annual Review we put the spotlight 

on just a few examples of the life-saving 

work happening at our Centres. 

For more information on our Institutes 

and Centres visit 

science.cancerresearchuk.org/research/ 

how-we-deliver-our-research 

Belfast 

Teams at our Belfast Centre are 

leading research into bowel, 

oesophageal and breast cancers. 

They are also exploring the latest 

techniques in radiotherapy, 

improving cancer diagnosis, and 

developing more effective drugs 

with fewer side effects. The Centre 

brings together over 40 researchers 

from across Northern Ireland. 

Ruth Boyd is a Senior Research 

and Information Nurse at Belfast 

City Hospital. Ruth is helping to 

recruit more cancer patients to 

clinical trials which could benefit 

thousands of people in the future. 

Dundee 

Research at our Dundee Centre 

particularly focuses on skin, bowel, 

and breast cancers. Scientists are 

also carrying out world-class 

research to refine and improve 

cancer surgery. 

Professor Inke Näthke and 

her team at the University 

of Dundee are carrying out 

work that could aid the early 

detection of bowel cancer. She 

is investigating a gene called 

APC, which is faulty in many 

cases of the disease. 

This work is important as it 

may help us develop techniques 

for identifying pre-cancerous 

tissue at an early stage when it 

still appears normal. This will give 

clinicians a chance to catch the 

disease in the early stages – when 

it can be treated more effectively. 

Southampton 

Scientists and doctors at our 

Southampton Centre are recognised 

internationally for their research into 

immunotherapy, a type of treatment 

that harnesses the power of the 

body’s own immune system to 

target cancer. 

Professor Peter Johnson, our 

Chief Clinician and one of the 

leaders of the Southampton 

Centre, is an expert in lymphoma. 

He and other researchers are 

developing a range of antibody 

and immunotherapy treatments, 

some of which are being tested 

in early-stage clinical trials. 

Joining the network of 

Centres is very important for 

patients, doctors and scientists in 

Southampton. It will strengthen 

the work we already do in bringing 

treatments straight from the 

laboratory to the clinic, and help 

us to do more work in important 

areas such as surgery. 

Newcastle 

Researchers at the Newcastle 

Centre at the Northern Institute 

for Cancer Research specialise 

in discovering and testing new 

treatments. Teams here have 

particular strengths in carrying out 

early-stage clinical trials of the latest 

treatments, and specialise in many 

types of cancer including childhood 

and prostate cancers. 

Professor Herbie Newell is an 

expert in cancer pharmacology 

– understanding how cancer 

drugs work inside the body. 

He and his team are currently 

working on targeted drugs that 

block the action of specific faulty 

proteins found within cancer cells, 

stopping the disease in its tracks. 

The development of 

personalised treatment – 

treatment that is tailored to the 

requirements of an individual 

patient – is becoming a reality and 

offers the opportunity to design 

new drugs that are truly selective 

for different forms of cancer. 

16 / Annual Review / Contents Driving world-class cancer research

Cardiff 

Teams at our Cardiff Centre are 

focusing on leukaemia as well as 

bowel, breast and urological cancers, 

such as prostate and bladder cancer. 

They are using laboratory discoveries 

to develop new ways to prevent, 

diagnose and treat the disease. 

Recent work by Dr Duncan Baird 

at Cardiff University takes us 

one step closer to a blood test 

that could predict how fast 

leukaemia will progress. Dr Baird 

is an expert on ‘telomeres’ – tiny 

structures that protect the ends 

of chromosomes, which hold 

our cells’ entire DNA blueprint. 

His team recently revealed how 

shortened and fused telomeres 

are involved in the progression of 

leukaemia. This discovery may help 

doctors identify people with more 

advanced cancer, so they can select 

the best treatment. 

Beatson Institute 

Paterson Institute 

Gray Institute 

Cambridge Research 

Institute 

London Research 

Institute 

Key 

Centres – our ten Centres of research excellence 

Institutes – our five core-funded research Institutes 

Other locations – just some of the other locations around the UK where 

we fund our life-saving research or support clinical trials 

Annual Review / Driving world-class Annual Review cancer / About research us / 17

Our people 

From our world-class scientists and lab 

assistants to our volunteers, our doctors and 

nurses to our staff, we rely on a wide variety 

of skills and experience to help us beat cancer. 

There are hundreds of thousands of people 

involved in helping us achieve our vision 

– they are all a vital part of our team, and 

we need each and every one of them. 

Here we highlight just a few of those that 

make our work possible. 

Senior scientist 

Professor Iain McNeish is a cancer specialist at Barts and 

the London School of Medicine, part of the Barts Cancer 

Research UK Centre. He specialises in the treatment of 

ovarian cancer. His research aims to understand the biology 

of ovarian cancer – in particular, the reasons why ovarian 

cancer cells can become resistant to chemotherapy. 

He wants to use this knowledge to design new types of 

treatment, such as gene therapy, to overcome resistance 

and make treatment successful for more women. 

The research Cancer Research UK does 

is high quality and focused on the one mission 

– to beat cancer. 

Professor Iain McNeish 

Ovarian cancer specialist 

18 / Annual Review / Our people

Campaigning ambassador 

When Chris Geiger was diagnosed with non-Hodgkin’s 

lymphoma, he was given just months to live. That was 20 years 

ago. Chris is now a passionate campaigner and ambassador for 

Cancer Research UK. He uses his personal experience to raise 

awareness of the amazing work that happens in our hospitals 

every day, and the important role we play in supporting patients. 

Our expert bloggers 

Science writers Henry Scowcroft, Ed Yong, Kat Arney 

and others write our award-winning science blog. 

They help people understand more about cancer research 

and the latest advances, including work we fund, as well 

as explaining health myths and media scares, and providing 

links to other helpful resources. Read more at 

scienceblog.cancerresearchuk.org 

Celebrity supporters 

Celebrities play an invaluable role when it comes to supporting 

and promoting our work. Sir Richard Branson, Sir Trevor 

MacDonald, Dame Judi Dench and Honor Blackman are 

among many others who have supported our campaigns, whilst 

legendary rocker Rod Stewart, Gary Barlow, Keane and Lemar 

are among many who have performed or supported our music 

events. British F1 Star Lewis Hamilton along with singer Leona 

Lewis and gold medallist Usain Bolt supported our Little Star 

Awards, which celebrate the courage of children with cancer. 

Shop volunteer 

Breast cancer survivor Doreen Walker volunteers 

two days a week at the Cancer Research UK shop on 

her local high street in Potters Bar. The grandmother 

of five sorts and prices clothes, serves customers and 

supervises the other volunteers. 

Relay For Life organiser 

Vanessa Babbage, who has been clear of breast cancer 

for two years now, helped organise a Relay For Life 

fundraising event in Crystal Palace. She coordinated 

the survivors’ ceremony and food for the day, then 

walked in the survivors’ lap of honour. The event raised 

£20,000 and Vanessa is chairing the committee to 

organise next year’s event. 

I’ve been on cloud nine since the Relay. It was 

just brilliant for everyone in the local community to 

come together and it’s so good to give something back 

to Cancer Research UK. Cancer changes you forever. 

I don’t worry about little things now because I know 

that what’s important is having a good quality of life. 

Vanessa Babbage 


Clinical trial nurse 

Marylyn Pilkington is a Senior Research Nurse at the 

Sir Bobby Robson Cancer Trials Research Centre in 

Newcastle. She works with patients who are taking 

part in early-phase clinical trials – trials for drugs that 

have shown promise in the laboratory and now need 

testing in the clinical setting. Marylyn gives patients the 

information they need to decide whether to take part, 

and supports them throughout the treatment. 

I really enjoy the work and want to give something 

back, and I think that goes for the other volunteers 

who have all been touched by cancer. I feel so fortunate 

that a routine screening helped to save my life. It never 

crossed my mind there would be a problem. But thank 

goodness I was invited to go along that day. 

Doreen Walker 


All new cancer drugs have to go through these 

early-phase trials. We’re hopeful that today’s trials 

will lead to the cancer treatments of the future. 

Marylyn Pilkington 

Clinical trial nurse 

Annual Review / Our people / 19

Raising money to support our work 

Our life-saving work is only possible thanks to 

the ongoing commitment and generosity of 

our supporters, as we receive no government 

funding for our research. 

We would like to thank them for helping us to raise a record 

£446 million. Here are just some of the ways they did it. 

Giving generously 

Our supporters set up regular donations by direct debit, 

donate online or give through a payroll scheme at work. 

Some people choose to give in celebration of a special 

event like a wedding, anniversary or birthday. Others donate 

in memory of a loved one. It’s also possible to give online 

to a specific research project through MyProjects. 

myprojects.cancerresearchuk.org 

Many people choose to continue their support for us by 

leaving a gift in their will. More than a third of our work 

is made possible by legacies, and last year we were left 

£157 million by generous donors. 

Joining a local group or organising your own fundraiser 

Across the UK, people support us by joining or forming 

local groups and committees. We have nearly 900 groups, 

committees and regular fundraisers all around the country. 

People also raise money individually – at school, home or 

work. Last year our supporters got involved in many ways, 

from hosting quiz nights and fundraising dinners to coffee 

mornings and head shaves. 

Getting active – taking part in an event or a challenge 

Our flagship, women-only event Race for Life has gone from 

strength to strength. In 2009, over 730,000 women came 

together at around 250 Race for Life events around the 

country. Together they raised an incredible £66 million. 

In April 2010 we launched Shine, our new night-time walking 

marathon. Shine was a great success, with more than 7,500 

people talking part in our first event in Manchester, raising over 

£1.4 million for our life-saving work. For the first time people 

could choose which cancer they wanted to beat and raise 

money specifically for that area of our work. 

We also held 22 Run10k events for men and women at 

fantastic locations across the country. And our overnight 

Relay For Life events, organised by volunteers, are a chance 

for supporters to team up with friends, family or colleagues. 

We have hundreds of events and challenges taking place across 

the UK for all fitness levels all year round. Find out more at 

supportus.cancerresearchuk.org/events 

Supporting us on the high street 

We have over 570 shops around the UK, where you can buy 

or donate goods. Despite it being a difficult year, our shops 

had their best week ever in December 2009, raising nearly 

£3 million. To make shopping even easier, we also have our 

own online shopping site selling a wide selection of products, 

including gifts and flowers. 

www.shoptobeatcancer.org.uk 

In partnership with business 

Our corporate supporters play a vital role in our work to beat 

cancer. Employees organise and take part in events and give up 

their time to volunteer with us. Last year we raised more than 

£5 million from our partnerships with various organisations – 

including TKMaxx, Superdrug and E.On. And other partners 

such as Tesco and Nivea sponsor our running events. 

I’ve taken part in Race for Life since my diagnosis in 2007. 

I walk it with my friends, and my daughter runs it too. It’s part 

of our year now. My husband was marshalling at the last 

Race for Life at 6.30am on his 60th birthday! That’s what it’s all 

about – everyone coming together to support each other. 

Deborah Huggons 


Major supporters 

We are grateful to our major supporters: individuals, 

grant-making trusts and foundations whose most generous 

contributions have helped to fund new buildings, items of 

equipment, Fellowship schemes and new areas of scientific 

research. We are delighted to acknowledge many of our 

supporters on page 28. 

Special events 

Every year we have a packed diary of special events. These 

include the Bobby Moore Fund Sports Ball, Sound & Vision, 

a series of concerts at Abbey Road Studios, the Chelsea Flower 

Show – where a generous supporter funds an inspirational 

garden – and our Christmas-time Emeralds & Ivy ball. 

Fundraising together – supporting foundations 

Last year we worked with Seve Ballesteros to create a new 

foundation to raise funds for brain cancer research. And we 

became a beneficiary of the Dallaglio Foundation in memory of 

Lawrence Dallaglio’s mother who died of cancer. This year we 

will continue to work in partnership with Seve and Lawrence 

to deliver high-profile events, such as gala dinners and celebrity 

music events, which will help fund our life-saving work. 

Fundraising for the future 

Give Change Make Change is a new way to give to charity 

while shopping online. Like a virtual charity-box, this novel 

idea allows people to round up their online shopping bill on 

partner websites and donate their ‘electronic spare change’. 

We are working with WWF, Great Ormond Street Hospital 

and the British Red Cross to launch the initiative. 

To find out more about how you can support us see 

pages 26 and 27, or visit 

www.cancerresearchuk.org/supportus 

20 / Annual Review / Raising money to support our work

Deborah Huggons, 53 

Race for Life participant and breast cancer survivor 

After noticing a lump in her breast, Deborah was 

diagnosed with breast cancer in 2007. She had 

a mastectomy and six months of chemotherapy. 

Deborah took part in the TACT-2 trial, which we helped 

fund. It compares different chemotherapy treatments 

to try to reduce side effects and improve long-term 

benefits. Now back to full health, Deborah ran the 

Barnstaple Race for Life with her daughter Esme. 

7.00am The dashing around begins, trying to get my 

children out of bed and on the school bus. 

8.30am Start work. I’m a careers advisor for young 

people with learning difficulties. 

1.00pm Grab a quick sandwich. 

7.15pm When I get home it’s a bit manic. We spend 

many of our evenings taking our children to 

after-school activities. Having cancer changed 

my priorities. Now I’m more focused on 

my family. 

11.30pm Bed, but I have to have some quiet time first. 

200trials 

We currently support 

around 200 clinical trials 

across the UK. With the 

help of people like Deborah 

and the vital funds raised 

by our supporters, trials 

like TACT-2 aim to make 

treatments more effective. 

Annual Review / Raising money Annual to Review support / our About work us / 21

How your donation helps 

us beat cancer 

We rely entirely on the money you give 

us and 90% of the donations we receive 

are £10 or under. Small donations can 

make a big difference. 

One gift of £10 could buy 300 glass slides for 

studying cells under the microscope. If 55,000 

people each give £10, they would pay for 

a research programme to test new drugs 

to treat women with breast cancer. 

Total cost of research work done during the year – £334m 

£37.4m 

Includes cervical, kidney, 

stomach, sarcoma, 

testicular, pharyngeal 

and over 100 other cancers 

£41.4m 

Breast 

£4.8m 

Brain 

£6.1m 

Bladder 

£9.4m 

Pancreatic 

£9.5m 

Non-Hodgkin’s 

Lymphoma 

£132.5m 

Basic research * 

£24.8m 

Bowel 

£10.6m 

Ovarian 

£11.9m 

Lung 

£13.3m 

Skin 

£15.0m 

Leukaemia 

£17.3m 

Prostate 

* 

In basic research, our scientists are working in laboratories to understand 

exactly how normal cells work and exactly how these processes go wrong 

in cancer. This research is vital, increasing our understanding of the molecular 

basis of the disease and laying the foundations for new ways to detect and 

treat many different types of cancer. 

22 / Annual Review / How your donation helps us beat cancer 

157

Lun 

Cancer research is very expensive… 

The average cost to run just one trial or laboratory 

is around £1 million per year, and research projects 

normally last several years. Research activities carried 

out in institutes, hospitals and universities throughout 

the UK cost £334 million. This figure reflects the cost 

of research work done this year. 

14 1 

We also spent £14 million on 57 our information and 

influencing work, raising awareness of cancer risks, 

providing better information to people affected by 

cancer and influencing public health policies. Total 

Cancer research is a long-term 

87 expenditure 

investment. This 308 

£467m year, 

due to the difficult economic climate and an overall 

308 

fall 

in voluntary giving to charities in the UK, it has been 

more important than ever that we keep a small amount 

of funds in reserve. This way, we will be able to continue 

our vital work in order to achieve our future goals. 

…but small donations add up 

Our supporters defied the recession by giving more than 

ever. Our fundraising income was £446 million – £13 million 

more than last year. This meant we were able to commit 

more towards our life-saving work to beat cancer. 

82 

65 

25 

Total 

fundraising 

income 

£446m 

94 

23 

157 

Legacies (People leaving us a gift in their will) 

Volunteer fundraising (Community fundraising 

– local events and appeals, including Relay For Life) 

Direct giving (Regular and one-off donations, 

payroll and online products) 

Events (National events such as Race for Life, 

Run10k and activities for the Booby Moore Fund) 

Shop income (Sales from donated goods and our own products) 

Other income (Including major gifts, corporate partnerships 

and shop donations) 

We will spend 80p in every £1 on fighting cancer… 

For every pound we receive, excluding our retail chain, 

80p is available to spend on our life-saving research, 

providing information and influencing public policy. 

…and the other 20p works hard too 

The money we spend on fundraising activities helps us 

to raise more than four times as much – for every £1 we 

spend on fundraising, excluding our retail chain, we raise 

over £4 more. And we are always looking for ways to 

make our fundraising operations more efficient. 

£1 

80p * 

• Research 

• Public-facing information 

• Influencing public policy 

20p 

• Cost of generating funds 

(excluding retail) 

£1 

£1 

£1 

£1 

£1 

* 

Funds available to spend on our work to beat cancer – 2009/10 

Annual Review / How your donation helps us beat cancer / 23

Professor David Neal, 59 

Leading expert on prostate cancer 

David is based at the Oncology Department of 

Addenbrooke’s Hospital, University of Cambridge. He leads 

the Cancer Research UK Uro-Oncology Group, which is 

looking into prostate cancer screening and other ways to 

beat the disease. A particular focus is identifying better ways 

of distinguishing aggressive cancers from non-aggressive 

ones so treatment can be better targeted. 

7.15am 

8.00am 

8.45am 

1.00pm 

6.30pm 

After cycling to work, I see a patient who has 

been admitted for robotic radical prostatectomy 

– a very precise way of removing cancerous 

prostate glands with the aid of a robot. 

Chair the urology departmental meeting 

to ensure we are doing our best to see people 

on time and treat them promptly. 

Go to the operating theatre. 

Meet with my research group, who are funded 

by Cancer Research UK. We are studying 

advanced prostate cancers to determine what 

new treatments might work in a disease that 

has become resistant to conventional treatments. 

Go home and have dinner. My wife and I take 

our two dogs for a walk, and I play the guitar 

before bed. 

£334m 

We support people like 

David, who is investigating 

the PSA test and if it 

should form the basis 

of a national screening 

programme. This year 

we spent £334 million on 

research activity like this 

in hospitals, institutes and 

universities across the UK. 

24 / Annual Review / Contents Meet our Executive Board

Meet our Executive Board 

Our supporters put a huge amount of time 

and effort into raising money to help beat 

cancer. Our Trustees, Executive Board, and 

all of our staff work hard to make sure every 

penny raised is used as effectively as possible. 

The Directors who made up our Executive Board 

in 2009/10 were: 

1 

2 3 4 

1/ Harpal Kumar MA MEng MBA 

Chief Executive Officer and Chairman of the Executive Board 

Harpal leads Cancer Research UK in our fight to beat cancer. 

He chairs our Executive Board and Scientific Executive 

Board and leads many of our key programes and initiatives. 

He co-chairs the National Awareness and Early Diagnosis 

Initiative and is a Board Member of the National Cancer 

Research Institute committees. He is also Deputy Chair 

of the Advisory Board for the Cancer Reform Strategy. 

2/ Aisling Burnand MBE 

Executive Director, Policy and Public Affairs 

Aisling is responsible for keeping cancer on the political agenda 

across the UK and in Europe. This includes developing our 

policies on cancer, science and other charity issues, and working 

with our supporters to influence politicians and civil servants. 

3/ Dr Lilian Clark PhD MBA 

Executive Director, Science Operations and Funding 

Lilian is responsible for the funding and administration of much 

of the research we support. She ensures that the research 

we fund is of the highest quality, and aligned to our vision. 

4/ Dr Iain Foulkes PhD 

Executive Director, Strategy and Planning 

Iain helps shape Cancer Research UK’s long-term strategic 

direction. He makes sure that, by having a clear and effective 

strategy, we are in a position to meet our ambitious goals. 

5/ Professor Peter Johnson MA MD FRCP 

Chief Clinician 

Peter is responsible for our clinical activities – our clinical 

research, the gathering of clinical input to guide our policy 

and much of our work on cancer prevention, diagnosis and 

treatment. He helps us to decide what direction we take in 

these areas and makes sure we have the plans in place to carry 

out this work. 

6/ Professor Sir David Lane FRS FRSE 

Chief Scientist 

David is a leading cancer research scientist, currently based 

in Singapore. He is responsible for helping to develop our 

scientific strategy ensuring that it is leading-edge and 

monitoring its implementation. He also plays a key role 

in attracting the top scientists to Cancer Research UK. 

5 6 7 8 

9 10 11 

7/ Sarah Lyness MA 

Executive Director, Communications and Information 

Sarah has helped make Cancer Research UK a well-known 

name in the UK. She is responsible for informing people 

about cancer and the work we do to fight it. 

8/ Lynne Robb BSc ACA 

Chief Financial Officer and Executive Director, 

Corporate Resources 

Lynne’s role covers a wide range of areas, including our 

finances, our investments and our legal position. She’s also 

responsible for our facilities and for making sure we manage 

the Charity in the most cost-effective way. 

9/ Elizabeth Sideris BA MSc 

Executive Director, Human Resources 

Elizabeth is responsible for Cancer Research UK’s people. 

She supports our staff, making sure they’re always developing, 

and looks for ways to make Cancer Research UK an enjoyable 

and rewarding place to work. 

10/ Dr Peter Sneddon PhD BSc DPhil(Oxon) 

Executive Director, Clinical and Translational 

Operations and Funding 

Peter is responsible for the operation and funding of clinical 

and translational research, which includes our vital clinical trials 

portfolio, our Cancer Research UK Centres and our drug 

discovery and development work. 

11/ Richard C Taylor 

Executive Director, Fundraising and Supporter Marketing 

Richard oversees our fundraising. He makes sure we have 

enough money coming in to fund our long-term goals. He leads 

a team to develop our five-year fundraising strategy and ensures 

that our fundraising is as effective and efficient as possible. 

For more information on our Executive Board visit 

www.cancerresearchuk.org/executiveboard 

Annual Review / Meet our Executive Board / 25

Constance Hoey, 55 

Race for Life participant and breast cancer survivor 

Constance discovered a lump under her right armpit 

while she was on holiday in May 2008. She underwent 

six months of chemotherapy and surgery to remove both 

breasts and 25 lymph nodes from each armpit, as well 

as radiotherapy. She was treated with Herceptin and 

Arimidex, and is now on Tamoxifen – all drugs that 

our research helped to develop. Now back at work 

as an administrative assistant, Constance took part 

in the Birmingham Race for Life earlier this year. 

6.00am Wake up and do 15 minutes of exercise. Then 

leave for work. I’ll have a light breakfast and take 

my tablets when I get there. 

12.00pm I like to go for a walk at lunchtime. 

2.00pm Finish work. I’m not ready for full-time work yet. 

But I’m getting better and stronger all the time. 

I might pop to the shops, prepare tea or potter 

in the garden. 

6.30pm Dinner with my husband Martin – he’s been 

a tower of strength. Afterwards we watch 

TV or a film together. 

10.00pm Try a little more exercise before going to bed. 

£41.4m 

This year we spent 

£41.4 million on life-saving 

breast cancer research. 

Our work covers all 

aspects of the disease, 

from its molecular causes 

through to developing new 

drugs and the psychological 

effects of treatment. 

26 / Annual Review / Contents Get involved and find out more

Get involved and find out more 

How you can help 

Do your own fundraising or join a group 

Organise a quiz, a sweepstake, a party – whatever 

you enjoy doing, use it to raise funds to fight cancer. 

If you don’t want to fundraise alone, join a group, 

or why not start your own? Find out more at 

supportus.cancerresearchuk.org/fundraising 

Take part in an event 

Whether you want to walk, run, cycle or swim, we have an 

event to suit you and to help us beat cancer. Get involved at 

supportus.cancerresearchuk.org/events 

Give your time 

If you have the time, we have the volunteering opportunity – 

from helping out in a shop or at an event, to raising awareness 

about Cancer Research UK in your community. Find out more at 

supportus.cancerresearchuk.org/volunteering 

Become a corporate partner 

Take part in staff fundraising, health promotion or commercial 

marketing partnerships and we will support you every step 

of the way. For more information visit 

cancerresearchuk.org/corporatepartnerships 

Visit our shops 

Donate your unwanted items, or come in for a browse 

and a bargain. You can also shop from your sofa at 

www.shoptobeatcancer.org.uk 

Make a donation – leave a lasting legacy 

Give monthly by direct debit or through payroll giving. 

Give in memory of a loved one or leave a life-saving legacy 

by remembering us in your will. However big or small, 

your donation will help us beat cancer. 

www.cancerresearchuk.org/donate 

It’s research that saved my life. There’s every chance that 

someone you know will benefit directly from the money you 

give to Cancer Research UK. 

Constance Hoey 


Information about cancer – prevention, treatment and care 

Get reliable information about cancer 

If you’re looking for information about cancer that’s up to 

date and easy to understand, visit our CancerHelp UK website. 

You can find out about cancer trials and research here too. 

www.cancerhelp.org.uk 

Speak to a specialist cancer nurse 

We have a team of specialist cancer nurses who can answer 

your questions in confidence. 

Call free on 0808 800 4040, Monday to Friday, 9am to 5pm. 

Or email using the contact form at 

www.cancerhelp.org.uk 

Talk to others affected by cancer 

Our online discussion forum Cancer Chat is your space to talk 

to other people affected by cancer, share experiences and find 

information at 

www.cancerchat.org.uk 

More about Cancer Research UK 

Visit our website 

For everything there is to know about Cancer Research UK, 

the work we do, and how you can support us, visit 

www.cancerresearchuk.org 

Join our Facebook page 

Meet other Cancer Research UK supporters, give messages 

of support, post details of events and share fundraising ideas 

www.facebook.com/cancerresearchuk 

Ask us questions or tell us what you think 

If you have a question or a comment about our work, 

we’d love to hear from you. 

Call our Supporter Services team on 020 7121 6699 

or send us a message through our website. 

www.cancerresearchuk.org/aboutus/contactus 

Donate to a project 

Choose the type of cancer you want to beat and donate 

to a specific project. Your reasons, your choice. 

Find out more at 

myprojects.cancerresearchuk.org 

Campaign with us 

Help us keep cancer at the top of the public agenda. 

Our supporters have successfully campaigned on issues 

from smokefree workplaces to improved cancer screening 

programmes. Get involved at 

www.cancercampaigns.org.uk 

Annual Review / Get involved and find out more / 27

Thank you 

We would like to thank everyone who 

has helped Cancer Research UK over the 

past year by investing their money, time 

and skills to make our work possible. 

In particular we would like to thank all the 

people that help us in our research by 

taking part in our clinical trials and helping 

in our population studies. Their support 

has made a huge difference. 

We would also like to thank the 

following organisations and individuals, 

including those who have chosen to 

remain anonymous – we are immensely 

grateful to everyone. 

Our Patron 

Her Majesty The Queen 

Our Joint Presidents 

HRH The Duke of Gloucester, KG, GCVO 

HRH Princess Alexandra 

the Hon. Lady Ogilvy, KG, GCVO 

Our corporate partners 

AT&T 

Beiersdorf UK Ltd 

British Airways plc 

Cheltenham Racecourse 

Compass Group UK and Ireland Ltd 

Deloitte LLP 

Diamond Insurance 

docrafts® 

FlyBe Ltd 

The Football Association 

Hearst Digital 

HSBC Bank plc 

ICAP 

J Sainsbury plc 

JT Ellis & Co Ltd 

Ladbrokes in the Community 

Charitable Trust 

Live Nation (Music) UK Ltd 

Lloyds Banking Group plc 

The London Marriott Business Council 

Mackays Stores Ltd 

Molton Brown Ltd 

Network Rail Infrastructure Ltd 

The Pampered Chef Ltd 

Peacocks Stores Ltd 

Premier Foods plc 

The Royal Bank of Scotland Group plc 

Sony Music Entertainment UK Ltd 

Sportsdirect.com Retail Ltd 

The Stobart Group 

Tesco plc 

TK Maxx and HomeSense 

Towergate Charitable Foundation 

Toyota Motor Manufacturing (UK) Ltd 

UK Mail Group plc 

Wembley National Stadium 

West Ham United 

Wm Morrison Supermarkets plc 

Our major supporters 

Milly Apthorp Charitable Trust 

Celia Atkin 

Awareness 

James Baldwin Trust 

Mr Seve Ballesteros 

The Band Trust 

The Barbour Trust 

Mark and Rebecca Baron 

Dr Christopher Beels 

Robert and Alison Bernays 

Tony Bramall Charitable Trust 

Bill Butlin Charity Trust 

David and Jennifer Buxton 

Edward Cadbury Charitable Trust 

Bill Cannon 

Catherine Cookson Charitable Trust 

Mr Keith C Cornwell 

Mr Lawrence Dallaglio OBE 

The Danego Charitable Trust 

Dr Naim Dangoor OBE 

DG Charitable Trust 

Mr & Mrs Martin Dawe 

Mr Cyril Dennis MBE 

Clive and Greta Dorey 

Collette Dove 

Mr Sydney Draper 

Mr David Dutton 

The Alice Edwards Charitable 

Foundation 

Team England Footballers’ Charity 

Eveson Charitable Trust 

Doris Field Charitable Trust 

Donald Forrester Trust 

The Freemasons’ Grand Charity 

Friends Provident Foundation 

Mr Jonathan Goldstein 

Mike Gooley Trailfinders Charity 

Sir Donald Gordon 

JWC Hands Charitable Trust 

Harhil Charitable Trust 

Mr Bob Harris 

Ada Hillard Charitable Trust 

The Marie Keating Foundation 

Mr Ronan Keating 

Robert and Anna King 

The Jimmy Knapp Cancer Fund 

Mr Stephen Knott 

Kirby Laing Foundation 

Laing O’Rourke Plc 

Kathleen Laurence Charitable Trust 

Richard Lawes Foundation 

Mr Brian Lay 

Leonora Children’s Cancer Fund 

Miss E M Lidbury Charitable Trust 

The Lipsaira Foundation 

Dr Iain MacKellar BVSc MRCVS 

The Mayfair Committee 

The McGrath Charitable Trust 

Fiona McHugh and Gertie McHugh, 

B. & M. McHugh Limited 

Debs McLean 

Barbara McLellan 

Laurence Misener Charitable Trust 

Stephanie Moore OBE 

The Musgrave Charitable Trust Ltd 

The Myristica Trust 

The North Sea Flight 85N 

Memorial Fund 

Oak Foundation 

Parthenon Trust 

Peacock Trust 

Plaw Hatch Hall Trust 

Lee and Caroline Portnoi 

Mr Glenn Poulter 

Nigel and Susan Pritchard 

Juliette Proudlove Memorial Fund 

Ranworth Trust 

Gerald Ronson Foundation 

Mr Justin Rose 

Mrs Sue Scott 

Mr Nigel Seabold 

ShareGift 

The Gill Gurdit Singh Fund 

Phillip and Vivien Sober 

Mrs John Somers 

Peter and Beryl Stevens 

Rhoddy and Georgina Swire 

Mr John Thomson 

Timpany Charitable Trust 

The Toby Charitable Trust 

Mr and Mrs Robin Tomkins 

John and Ann-Margaret Walton 

Garfield Weston Foundation 

Pamela Williams Charitable Trust 

Foster Wood Foundation 

Mrs Humphrey Wood MBE 

Mr Thomas Wood 

Lennox and Wyfold Foundation 

Yelsel Trust 

Zochonis Charitable Trust 

Our Trustees 

David Newbigging OBE Chairman 

Dr Melanie G Lee CBE BSc DSc(Hon) 

FMedSci Deputy Chairman 

Professor Anton Berns PhD 

(appointed 30 March 2010) 

Professor Colin C Bird CBE FRSE 

Dr Philip H M Campbell BSc MSc PhD 

DSc FInstP FRAS 

Sir James Crosby BA FFA 

Liz A Hewitt FCA BSc(Econ) FRSA 

Roger Matthews ACA BSocSci 

Dame Bridget Ogilvie AC DBE FRS 

Dr Keith F Palmer OBE Treasurer 

Michael Pragnell MA(Oxon) 

MBA(INSEAD) 

(appointed 30 March 2010) 

Leah J Sowden FCA CTA DChA 

Professor Jeffrey Tobias MD 

FRCP FRCR 

Professor Sir Kenneth Calman KCB DL 

FRSE (retired 31 December 2009) 

28 / Annual Review / Thank you

More about Cancer Research UK 

For everything there is to know about 

Cancer Research UK visit 


We are committed to a series of social and 

environmental goals. You can find out more 

about these at 

aboutus.cancerresearchuk.org/sustainability 

A great deal of cancer research is carried out without 

using animals, but in certain areas animal research remains 

essential if we are to understand, prevent and cure cancer. 

Cancer Research UK only uses animals when there 

is no alternative. 

Cancer patients and their families are at the heart of 

everything we do. We believe that all our research is vital 

if we are to save the lives of more patients in the future. 

Cancer Research UK is a member of the Association of 

Medical Research Charities and endorses the AMRC's 

position on the use of animals in medical research. 

A PDF of both our Annual Review and Annual Report 

and Accounts can be downloaded at 


Registered charity number in England and Wales 1089464 

Registered charity number in Scotland SC041666 

Registered company number 4325234 

Copyright © 2010 Cancer Research UK 

Design: NB Studio 

Photography: Spike Watson 

Printed on 9 Lives Offset 100% recycled paper with 

environmentally credible printing technology and using 

inks made from vegetable based oils. Printer is carbon 

neutral and ISO14001 and EMAS registered.

Cancer Research UK 

Registered address: 

61 Lincoln’s Inn Fields 

London WC2A 3PX 

T +44(0)20 7242 0200 


LF013

Making an impact - Cancer Research UK

Create successful ePaper yourself

Delete template?

Save as template?